| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Elvia Rodríguez-Villalobos, Fernando Cervantes-Aguayo, Enrique Vargas-Salado, María Elena Avalos-Muñoz, Dulce María Juárez-Becerril, Ector Jaime Ramírez-Barb. [Diabetic retinopathy: twelve-year incidence and progression]. Cirugia y cirujanos. vol 73. issue 2. 2005-10-17. PMID:15910698. |
diabetic retinopathy (dr) it is the main cause of preventable blindness in productive-age adults. |
2005-10-17 |
2023-08-12 |
Not clear |
| Elvia Rodríguez-Villalobos, Fernando Cervantes-Aguayo, Enrique Vargas-Salado, María Elena Avalos-Muñoz, Dulce María Juárez-Becerril, Ector Jaime Ramírez-Barb. [Diabetic retinopathy: twelve-year incidence and progression]. Cirugia y cirujanos. vol 73. issue 2. 2005-10-17. PMID:15910698. |
the rate of progression to blindness from dr differs among countries and populations. |
2005-10-17 |
2023-08-12 |
Not clear |
| S Subedi, K U Subedi, B P Badh. Doctor's role in early detection of diabetic retinopathy and prevention of blindness from its complications. JNMA; journal of the Nepal Medical Association. vol 44. issue 157. 2005-10-13. PMID:16152680. |
diabetic retinopathy (dr) is a microangiopathy, which is caused by chronic hyperglycemia, affecting the retinal arterioles, capillaries and venules, complications of which lead to incurable blindness. |
2005-10-13 |
2023-08-12 |
Not clear |
| K G Santos, B Tschiedel, J R Schneider, K E P Souto, I Roisenber. Prevalence of retinopathy in Caucasian type 2 diabetic patients from the South of Brazil and relationship with clinical and metabolic factors. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 38. issue 2. 2005-10-03. PMID:15785833. |
diabetic retinopathy (dr) is a sight-threatening chronic complication of diabetes mellitus and is the leading cause of acquired blindness in adults. |
2005-10-03 |
2023-08-12 |
Not clear |
| Cristiano Giust. Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy? Medical hypotheses. vol 63. issue 2. 2005-02-24. PMID:15236781. |
diabetic retinopathy (dr) is a major cause of blindness in the working population of the western world and there is no doubt that its prevalence is strongly related to the duration of diabetes and the glycemic control. |
2005-02-24 |
2023-08-12 |
human |
| Karin S Coyne, Mary Kay Margolis, Tessa Kennedy-Martin, Timothy M Baker, Ronald Klein, Matthew D Paul, Dennis A Revick. The impact of diabetic retinopathy: perspectives from patient focus groups. Family practice. vol 21. issue 4. 2004-12-21. PMID:15249536. |
diabetic retinopathy (dr) affects 50-85% of people with diabetes and may result in visual impairment or blindness. |
2004-12-21 |
2023-08-12 |
Not clear |
| C Giust. Retinopathy in juvenile diabetes: a 10-year (1990-2000) review. Pediatric diabetes. vol 2. issue 2. 2004-06-30. PMID:15016202. |
there is general agreement that early diagnosis and treatment of dr can slow its progression and help to prevent blindness. |
2004-06-30 |
2023-08-12 |
Not clear |
| Dominique Chauvau. [Non-insulin-dependent diabetes: an expanding disease. Diabetic ophthalmopathy: diabetic retinopathy facts]. Bulletin de l'Academie nationale de medecine. vol 187. issue 7. 2004-06-01. PMID:15146607. |
diabetic retinopathy (dr) is the 5th cause of blindness in the population of less than 50 years old in industrialized countries. |
2004-06-01 |
2023-08-12 |
Not clear |
| G Grass. Diabetic retinopathy. Minerva medica. vol 94. issue 6. 2004-05-13. PMID:14976470. |
diabetic retinopathy (dr) in the way of proliferative retinopathy (pdr) and macular oedema (me) is the commonest cause of new cases of legal blindness in europe as in north america in the age group 30 to 70-74 years. |
2004-05-13 |
2023-08-12 |
Not clear |
| Thomas A Ciulla, Armando G Amador, Bernard Zinma. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes care. vol 26. issue 9. 2004-04-23. PMID:12941734. |
diabetic retinopathy (dr) and diabetic macular edema (dme) are leading causes of blindness in the working-age population of most developed countries. |
2004-04-23 |
2023-08-12 |
Not clear |
| W-J Liu, L-T Lee, M-F Yen, T-H Tung, R Williams, S W Duffy, T H-H Che. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabetic medicine : a journal of the British Diabetic Association. vol 20. issue 9. 2003-12-09. PMID:12925052. |
therefore, the natural history of dr and rates of transition after treatment (including metabolic control and laser photocoagulation) from no diabetic retinopathy (ndr) to blindness were quantified. |
2003-12-09 |
2023-08-12 |
Not clear |
| V S Lysenk. [Modern understanding of the pathogenesis of pre-proliferative diabetic retinopathy]. Vestnik Rossiiskoi akademii meditsinskikh nauk. issue 5. 2003-08-19. PMID:12800490. |
diabetic retinopathy (dr) is a severe and late complication of diabetes mellitus leading, in a majority of cases, to poor vision and blindness. |
2003-08-19 |
2023-08-12 |
Not clear |
| Alistair J Barbe. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Progress in neuro-psychopharmacology & biological psychiatry. vol 27. issue 2. 2003-05-29. PMID:12657367. |
diabetic retinopathy (dr) is a common complication of diabetes and a leading cause of legal blindness in working-age adults. |
2003-05-29 |
2023-08-12 |
Not clear |
| b' B Kalvodov\\xc3\\xa. [Screening for diabetic retinopathy in the Czech Republic--guideline]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. vol 58. issue 1. 2002-03-07. PMID:11852551.' |
the authors evaluate the priorities of dr screening, the final effect of which is a decline of blindness caused by dm. |
2002-03-07 |
2023-08-12 |
human |
| T Ishibash. [Cell biology of intraocular vascular diseases]. Nippon Ganka Gakkai zasshi. vol 103. issue 12. 2000-02-23. PMID:10643294. |
diabetic retinopathy (dr) still remains the leading cause of blindness in the working population of japan and western world, though therapies such as retinal photocoagulation and vitrectomy can be remarkably effective when administered at an appropriate stage in the disease process. |
2000-02-23 |
2023-08-12 |
mouse |
| V C Chow, R P Pai, J R Chapman, P J O'Connell, R D Allen, P Mitchell, B J Nankivel. Diabetic retinopathy after combined kidney-pancreas transplantation. Clinical transplantation. vol 13. issue 4. 1999-10-14. PMID:10485379. |
in summary, uremic patients from diabetic nephropathy had a high prevalence of severe proliferative dr and blindness at the time of presentation for spk. |
1999-10-14 |
2023-08-12 |
Not clear |
| M Kuroki, M Kawakam. [Diabetic retinopathy--the mechanisms of the ocular neovascularization and the development of anti-angiogenic drugs]. Nihon rinsho. Japanese journal of clinical medicine. vol 57. issue 3. 1999-05-18. PMID:10199138. |
ocular neovascularization contributes to severe visual loss of the patients with diabetic retinopathy (dr) which is the leading cause of blindness on adults of working age. |
1999-05-18 |
2023-08-12 |
Not clear |
| E J Mayer-Davis, R A Bell, B A Reboussin, J Rushing, J A Marshall, R F Hamma. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology. vol 105. issue 12. 1998-12-18. PMID:9855158. |
diabetic retinopathy (dr) is a major cause of visual impairment and blindness in adults. |
1998-12-18 |
2023-08-12 |
Not clear |
| C González Villalpando, M E González Villalpando, S Martínez Díaz, D Rivera Martínez, B Arredondo Pérez, S Islas Andrade, M P Ster. A diabetic retinopathy screening program as a strategy for blindness prevention. Archives of medical research. vol 28. issue 1. 1997-05-12. PMID:9078600. |
the most frequent cause of preventable blindness in adults, in the developed world, is diabetic retinopathy (dr). |
1997-05-12 |
2023-08-12 |
human |
| M E González, C González, M P Stern, B Arredondo, S Martínez Día. Concordance between retina specialists and a preferred practice pattern in treatment and follow-up criteria for diabetic retinopathy. The Mexico City Diabetes Study Retinopathy Group. Archives of medical research. vol 27. issue 2. 1996-09-04. PMID:8696066. |
proper detection, adequate laser therapy and follow-up of diabetic retinopathy (dr), using guidelines established by landmark studies, are important to prevent blindness. |
1996-09-04 |
2023-08-12 |
Not clear |